We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Olympus Subsidiary for Multiple QS Violations
FDA Cites Olympus Subsidiary for Multiple QS Violations
April 16, 2010
A Japanese subsidiary of Olympus has received an FDA warning letter citing it for several quality system (QS) violations.